Similar articles

• An update on the role of ploidy in prostate carcinoma.

  Peters-Gee JM. Peters-Gee JM. Henry Ford Hosp Med J. 1992;40(1-2):99-102. Henry Ford Hosp Med J. 1992. PMID: 1428988 Review.
• [Digital image analysis in pathology--exemplified in prostatic cancer].

  Danielsen HE, Kildal W, Sudbø J. Danielsen HE, et al. Tidsskr Nor Laegeforen. 2000 Feb 10;120(4):479-88. Tidsskr Nor Laegeforen. 2000. PMID: 10833941 Review. Norwegian.
• Nuclear/Nucleolar morphometry and DNA image cytometry as a combined diagnostic tool in pathology of prostatic carcinoma.

  Kavantzas N, Agapitos E, Lazaris AC, Pavlopoulos PM, Sofikitis N, Davaris P. Kavantzas N, et al. J Exp Clin Cancer Res. 2001 Dec;20(4):537-42. J Exp Clin Cancer Res. 2001. PMID: 11876548
• Fluorescence image cytometry for measurement of nuclear DNA content in surgical pathology.

  Wang N, Pan Y, Heiden T, Tribukait B. Wang N, et al. Cytometry. 1995 Dec 15;22(4):323-9. doi: 10.1002/cyto.990220409. Cytometry. 1995. PMID: 8749783
• Prostatic dysplasia: significance in relation to nuclear DNA ploidy studies of prostate adenocarcinoma.

  Lieber MM. Lieber MM. Urology. 1989 Dec;34(6 Suppl):43-8. Urology. 1989. PMID: 2603285 No abstract available.